Cite

HARVARD Citation

    Richards, D. et al. (2019). HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality. Journal for immunotherapy of cancer. 7 (1), p. . [Online]. 
  
Back to record